Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

BBIOVIE INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
B

BIOVIE INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
    Sep 15, 2026BioVie Inc. Press Releases
  • BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
    Sep 14, 2026BioVie Inc. Press Releases
  • BioVie Announces Update to Parkinson’s Phase 3 Development Program
    Sep 8, 2026BioVie Inc. Press Releases
  • BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
    Aug 31, 2026BioVie Inc. Press Releases
  • BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
    Aug 6, 2026BioVie Inc. Press Releases
  • Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
    May 27, 2026BioVie Inc. Press Releases
  • BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
    May 26, 2026BioVie Inc. Press Releases
  • BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
    May 18, 2026BioVie Inc. Press Releases
  • BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026
    Apr 27, 2026BioVie Inc. Press Releases
  • BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
    Apr 14, 2026BioVie Inc. Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$1.40Close · Oct 7, 2026